Background: Chronic obstructive pulmonary disease (COPD) is a syndrome of chronic
progressive airflow limitation which occurs as a result of chronic inflammation of the airways …

Chronic obstructive pulmonary disease (COPD), a disease that encompasses emphysema,
chronic obstructive bronchitis and small airway obstruction and that is characterised by …

Inhaled corticosteroids are often used to manage chronic obstructive pulmonary disease,
although the evidence regarding their long-term efficacy in preventing or reducing adverse …

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of
infections such as pneumonia. Pneumonia among patients with COPD carries a higher risk …

Background. The cardiovascular (CV) safety of inhaled corticosteroids (ICSs) in chronic
obstructive pulmonary disease (COPD) is controversial because different studies have …

Current national and international guidelines recommend the use of inhaled corticosteroids
(ICS) in addition to long-acting bronchodilators in people with more severe COPD to reduce …

Withdrawal of inhaled corticosteroids is known to worsen disease control in bronchial
asthma but similar data are lacking in chronic obstructive pulmonary disease (COPD). We …

Inhaled corticosteroids have been the backbone of asthma therapy for the past 20 plus
years. Although they have, for the most part, been effective in controlling asthma symptoms …

Objective To determine the extent of inhaled corticosteroid use among patients with chronic
obstructive pulmonary disease (COPD). Design Review of medical records. Setting Tertiary …

Chronic obstructive pulmonary disease (COPD) guidelines suggest using inhaled
corticosteroids (ICS) in patients with severe airflow limitation or those at high risk of …